ConductScience.org, home
A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's Disease
API referenceFor AI assistants

Trial · NCT01711866

Results by group14

Each measurement the trial posted, group by group, in the words and numbers it posted.

1 to 14 of 14

Download this page as JSON
OutcomeGroupCategoryValueSpreadUnits
Clinical Global Impression (CGI) Item 4 (Side Effects) at the End of the Treatment Period or Early Withdrawal VisitRotigotineCGI Item 4 score of 158participants
Clinical Global Impression (CGI) Item 4 (Side Effects) at the End of the Treatment Period or Early Withdrawal VisitRotigotineCGI Item 4 score of 226participants
Clinical Global Impression (CGI) Item 4 (Side Effects) at the End of the Treatment Period or Early Withdrawal VisitRotigotineCGI Item 4 score of 33participants
Clinical Global Impression (CGI) Item 4 (Side Effects) at the End of the Treatment Period or Early Withdrawal VisitRotigotineCGI Item 4 score of 40participants
Clinical Global Impression (CGI) Item 4 (Side Effects) at the End of the Treatment Period or Early Withdrawal VisitRotigotineCGI Item 4 score of 3 or 43participants
Patients Global Impressions of Change (PGIC) at the End of the Treatment Period or Early Withdrawal VisitRotigotinePGIC category 15participants
Patients Global Impressions of Change (PGIC) at the End of the Treatment Period or Early Withdrawal VisitRotigotinePGIC category 217participants
Patients Global Impressions of Change (PGIC) at the End of the Treatment Period or Early Withdrawal VisitRotigotinePGIC category 330participants
Patients Global Impressions of Change (PGIC) at the End of the Treatment Period or Early Withdrawal VisitRotigotinePGIC category 418participants
Patients Global Impressions of Change (PGIC) at the End of the Treatment Period or Early Withdrawal VisitRotigotinePGIC category 510participants
Patients Global Impressions of Change (PGIC) at the End of the Treatment Period or Early Withdrawal VisitRotigotinePGIC category 63participants
Patients Global Impressions of Change (PGIC) at the End of the Treatment Period or Early Withdrawal VisitRotigotinePGIC category 71participants
Patients Global Impressions of Change (PGIC) at the End of the Treatment Period or Early Withdrawal VisitRotigotinePGIC category ≥ 514participants
Patients Global Impressions of Change (PGIC) at the End of the Treatment Period or Early Withdrawal VisitRotigotinePGIC category ≥ 64participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01711866/results

API referenceFor AI assistants